FindTrial
Sign In

Kashmari phal in excessive bleeding during menstruation

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF KASHMARI PHAL IN ASRIGDARA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028989
Enrollment
5
Registered
2020-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Kashmari phal: Kashmari phal 5gm Orally with warm water twice a day for 2 months. Control Intervention1: Nil: Nil

Sponsors

DrVaishali Dave
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 13- 45 years. and willing to give their consent to participate in the study. Patients with pratyatma lakshanas of asrigdara. Patients diagnosed as DUB

Exclusion criteria

Exclusion criteria: Patients with chronic illness. Patients using intrauterine contraceptive device. Patients with uterine and Pelvic pathology. Benign and malignant growth. Threatened , spontaneous or incomplete/ Ectopic pregnancy

Design outcomes

Primary

MeasureTime frame
Kashmari phal will be effective in controlling excessive bleeding during menstruationTimepoint: 4 week , then 8th week after treatment—

Secondary

MeasureTime frame
Reoccurrence of Condition will be preventedTimepoint: after 2 months—

Countries

India

Contacts

Public ContactDr Vaishali Dave

J S Ayurveda Mahavidyalay

vaishalivasavda@gmail.com9662140078

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026